About

MISSION STATEMENT AND VISION

JoMO is a source where optometrists and other eye care  professionals can go to publish and learn about medical optometry. The specialty of Medical Optometry encompasses the medical diagnosis, management and treatment of primary and secondary diseases and disorders of the human eye, adnexa and visual tracts. Our vision is to create a journal that offers focused case reports with literature reviews as well as original research and articles. A journal where doctors can go to find focused answers for the care of their patient as well as answers to questions they didn’t know they had.

TYPES OF ARTICLES

Original articles, original research, case report and literature reviews, article reviews, textbook reviews, photo essays, theme/recurring columns, editorial columns, “guess-the-disease” images and letters to the editor.

JOURNAL INFORMATION

Publication model: Open access
Publishing formats: Online format
Publication frequency:Quarterly
Launch date: Spring 2023
Peer Review model: Double blind
Journal Online ISSN: : 2996-0991

JOURNAL STATISTICS

Acceptance rate: 69%
Average time between submission & first decision: 7 days
Average time between submission & publication: 102 days

AUTHOR FEES

JoMO does not charge any fees to authors.

RIGHTS AND PERMISSIONS  

COPYRIGHTS

Authors of JoMO articles retain the right to reuse material from their own articles in their future work, with proper attribution. Permission does not need to be obtained from JoMO.

PERMISSIONS

Material from articles published may be reused in the manner specified by the Creative Commons license applied to the article – the CC BY-NC-ND (Creative Commons Attribution-NonCommercial-NoDerivs) Permission does not need to be obtained from JoMO

Authors hold the copyright of their own published articles. If you would like to reuse material in a manner not permitted by an article’s Creative Commons license, please contact the authors for permission.

Policies

See the Journal of Medical Optometry Policies

OPEN ACCESS

The article processing charge (APC) will be paid by ABCMO so authors of accepted peer-reviewed articles will receive perpetual unrestricted online access to their published article to readers globally, immediately upon publication. All articles are subject to the journal’s standard peer review process and will be accepted or rejected based on their own merit.

Before writing a full article, please use the portal link in the Submissions Tab to submit an abstract for review. The Journal of Medical Optometry uses a Double-Blind Peer Review process so all author information will be removed before the review begins. With that in mind, make sure you eliminate subtle “identifiers” such as Employers or Facilities from your abstract before submission.

In Partnership With

Subscribe


Our Authors

1 post(s)
General Practitioner from Mérida, Yucatán, and a proud graduate of UPAEP.
14 post(s)
Dr. Rett is the Editor-in-Chief of the Journal of Medical Optometry and the secretary for the American Board of Certification…
4 post(s)
Dr. Leslie Wilderson, OD, FAAO, Dipl AAO earned both her Bachelor of Science in Vision Science and Doctor of Optometry…
1 post(s)
Dr. Emily Coan graduated from the Southern California College of Optometry in 2025 and completed a residency in Ocular Disease…
5 post(s)
Dr. Canellos is a full-time faculty member of SUNY State College of Optometry. She is an Associate Clinical Professor, Instructor…
2 post(s)
Dr. Muscente is an optometrist practicing at Richmond University Medical Center and Level 1 Trauma Center. He is a graduate…
13 post(s)
Dr. Kane graduated from New England College of Optometry in 2015 and went on to complete an ocular disease/primary care…
1 post(s)
Dr. Glass earned her optometry degree from the University of Houston College of Optometry. Her training included rotations in ocular…
1 post(s)
Len Koh is a staff optometrist and residency site director at the Mann-Grandstaff VA Medical Center in Spokane, Washington. He…
1 post(s)
Dr. Wang graduated from the New England College of Optometry in 2025. She completed her ocular disease residency at the…